PROSTACT Trademark

Trademark Overview


On Thursday, September 12, 2024, a trademark application was filed for PROSTACT with the United States Patent and Trademark Office. The USPTO has given the PROSTACT trademark a serial number of 79408021. The federal status of this trademark filing is REGISTERED as of Tuesday, August 5, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The PROSTACT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals
prostact

General Information


Serial Number79408021
Word MarkPROSTACT
Filing DateThursday, September 12, 2024
Status700 - REGISTERED
Status DateTuesday, August 5, 2025
Registration Number7877202
Registration DateTuesday, August 5, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 17, 2025

Trademark Statements


Goods and ServicesScientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals
Description of MarkThe mark consists of a design of a circle with two lines on the left side going upward and two lines on the right side going to the right. The wording "PROSTACT" appears to the right in a stylized font.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 31, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTelix Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, October 31, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 4, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, November 26, 2024ASSIGNED TO EXAMINER
Monday, December 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, December 3, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 15, 2024REFUSAL PROCESSED BY MPU
Sunday, December 15, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, January 5, 2025REFUSAL PROCESSED BY IB
Thursday, April 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 17, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 11, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 17, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 17, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 5, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, August 5, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 5, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB